Category Archives:
Infosys approves share buyback worth $2 billion
(Reuters) -India's No.2 IT services provider Infosys approved a share buyback worth 180 billion rupees ($2.04 billion), the company said on Thursday. The company said it had set a buyback price of 1,8...
Thomson Reuters Sep 11, 2025
Pentagon starts process of finding Golden Dome contractors
By Mike Stone WASHINGTON (Reuters) -The Pentagon's Missile Defense Agency has begun the process of doling out contracts for President Donald Trump's marquee Golden Dome missile defense shield, accordi...
Thomson Reuters Sep 11, 2025
ECB's Lagarde signals no rush to rescue France on bond market
By Francesco Canepa and Balazs Koranyi FRANKFURT (Reuters) -European Central Bank President Christine Lagarde signalled no rush on Thursday to intervene in the bond market to support France, which has...
Thomson Reuters Sep 11, 2025
Southwest Airlines flight suffers engine failure, safely diverts
(Reuters) -A Southwest Airlines jet suffered an apparent engine failure Thursday after departing from Hollywood Burbank Airport, prompting the Phoenix-bound Boeing 737-700 to safely divert to Los Ange...
Thomson Reuters Sep 11, 2025
JPMorgan promotes Abularach and Johnson to lead infrastructure investment banking
By Nupur Anand NEW YORK (Reuters) -JPMorgan Chase appointed Francisco Abularach and Michael Johnson as its new global co-heads of infrastructure investment banking, according to a memo seen by Reuters...
Thomson Reuters Sep 11, 2025
US, India 'not that far apart' on tariffs, says Trump's India nominee
By Patricia Zengerle WASHINGTON (Reuters) -Republican President Donald Trump's nominee to be the U.S. ambassador to India said on Thursday that Washington and New Delhi are "not that far apart" on tar...
Thomson Reuters Sep 11, 2025
AbbVie shares hit record high as key immunology drug set for exclusivity until 2037
By Christy Santhosh (Reuters) -AbbVie shares rose 4% to a record high on Thursday after the U.S. drugmaker said it expected no generic competition for its blockbuster immunology drug Rinvoq until 2037...
Thomson Reuters Sep 11, 2025
FDA panel to weigh in on AI mental health devices
(Adds dropped word 'in' in headline) (Reuters) - The U.S. Food and Drug Administration will hold an advisory panel meeting in November to examine the fast-emerging class of AI-enabled digital mental h...
Thomson Reuters Sep 11, 2025
Lebanon cabinet grants licence to Elon Musk's Starlink
BEIRUT (Reuters) -Lebanon's cabinet granted a licence to Starlink, the satellite internet firm led by billionaire Elon Musk, to provide internet services in the country, the state news agency NNA said...
Thomson Reuters Sep 11, 2025
Ferragamo CFO La Tour resigns, La Morgia takes interim role
MILAN (Reuters) -Ferragamo's Chief Financial Officer Pierre La Tour is leaving the company as of September 26, after one and a half years in the role, to pursue new professional opportunities, the Ita...
Thomson Reuters Sep 11, 2025
Weather information is not currently available at this location.